Skip to search.
 TSX Down 1.79% TSX Ventures Up 0.02%

Athersys, Inc. (ATHX)

-NasdaqCM
1.16 Down 0.07(5.69%) Feb 8, 4:00PM EST
Prev Close:1.23
Open:1.22
Bid:1.08 x 1000
Ask:2.50 x 10000
1y Target Est:4.25
Beta:-1.18587
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:1.15 - 1.22
52wk Range:0.90 - 3.43
Volume:341,340
Avg Vol (3m):403,642
Market Cap:96.66M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ATHXDown 5.69%96.66M
OSIRDown 2.50%214.64M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):64.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Dec-15) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback